bioAffinity Technologies (BIAF) Invested Capital: 2022-2025
Historic Invested Capital for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $9.0 million.
- bioAffinity Technologies' Invested Capital rose 122.81% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 122.81%. This contributed to the annual value of $3.4 million for FY2024, which is 43.17% down from last year.
- Per bioAffinity Technologies' latest filing, its Invested Capital stood at $9.0 million for Q3 2025, which was up 562.42% from -$2.0 million recorded in Q2 2025.
- bioAffinity Technologies' Invested Capital's 5-year high stood at $22.0 million during Q3 2022, with a 5-year trough of -$2.0 million in Q2 2025.
- Over the past 3 years, bioAffinity Technologies' median Invested Capital value was $6.1 million (recorded in 2023), while the average stood at $5.4 million.
- Over the last 5 years, bioAffinity Technologies' Invested Capital had its largest YoY gain of 122.81% in 2025, and its largest YoY loss of 143.82% in 2025.
- Quarterly analysis of 4 years shows bioAffinity Technologies' Invested Capital stood at $11.3 million in 2022, then plummeted by 46.38% to $6.1 million in 2023, then slumped by 43.17% to $3.4 million in 2024, then spiked by 122.81% to $9.0 million in 2025.
- Its last three reported values are $9.0 million in Q3 2025, -$2.0 million for Q2 2025, and $2.2 million during Q1 2025.